[EN] HETEROCYCLYLAMIDES AS GUT MICROSOMAL TRIGLYCERIDE TRANSPORT PROTEIN INHIBITORS<br/>[FR] HÉTÉROCYCLYLAMIDES COMME INHIBITEURS DE LA PROTÉINE DE TRANSPORT DE TRIGLYCÉRIDES MICROSOMAL DE L'INTESTIN
申请人:SIRTRIS PHARMACEUTICALS INC
公开号:WO2009014674A1
公开(公告)日:2009-01-29
Compounds represented by formula (I) are inhibitors of gut microsomal triglyceride transfer protein. Such compounds are useful in treating diseases or conditions such as diabetes and obesity, along with patients are risk for developing such diseases or conditions.
Stereospecificannulation of hydroxyvinylethers in the presence of triflic anhydride and tertiary amines and its syntheticapplication are described. Each 1-hydroxy-2-oxabicyclo[n.4.0]alkane, 2-oxabicyclo[n.4.0]alk-1(6)-ene and 2-oxabicyclo[n.4.0]alk-1(6+n)-ene is stereoselectively synthesized from the same hydroxyvinylether depending on the choice of the reaction conditions (temperature, solvent
描述了在三氟甲磺酸酐和叔胺存在下的羟基乙烯基醚的立体定向环氧化及其合成应用。每个1-羟基-2-氧杂双环[n.4.0]烷烃,2-氧杂双环[n.4.0] alk-1(6)-烯和2-氧杂双环[n.4.0] alk-1(6 + n)-烯根据反应条件(温度,溶剂和叔胺)的选择,由相同的羟基乙烯基醚立体选择性地合成。这些化合物导致多官能化的环状化合物和一些天然产物。我们提出,这种环化反应是通过纯S N 2样机理进行的。
Gut microsomal triglyceride transport protein inhibitors
申请人:Vu Chi B.
公开号:US20080249130A1
公开(公告)日:2008-10-09
Compounds represented by formula (I):
are inhibitors of gut microsomal triglyceride transfer protein. Such compounds are useful in treating diseases or conditions such as diabetes and obesity, along with patients are risk for developing such diseases or conditions.
Hexahydrobenzofurane und Hexahydrochromene - Verfahren zur Herstellung und ihre Verwendung als Duftstoffe
申请人:Symrise AG
公开号:EP3026048A1
公开(公告)日:2016-06-01
Die Erfindung betrifft neue Verbindungen der Formel
mit R = -methyl oder ethyl,
R1=-H, -methyl, ethyl, O-methyl oder O-ethyl und
X= -CH2- oder -CH2-CH2-,
deren Verwendung als Duftstoffe, bevorzugte Mischungen, Konsumgüter enthaltend diese Verbindungen und deren Herstellung.
The present invention provides an odor-modulating agent that modulates malodors generated in daily living environments or industries to different odors so that harm caused by the malodors can be easily solved, and an odor-modulating method. Specifically, the present invention provides an odor-modulating agent comprising at least one oxygen-containing cyclic compound selected from the group consisting of furan compounds, pyran compounds, and cyclopentanone derivatives.